News

Welcome to our newsroom. Here you will find all the latest news about Bristol Myers Squibb in Belgium. As a journalist, you will also find all press releases, contact details and visual material here.

Latest news

Sotyktu approval
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis >

Bristol Myers Squibb today announced that the European Commission has approved Sotyktu (deucravacitinib), a first-in-class, selective tyrosine kinase 2 (TYK2) inhibitor, for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy, representing a new way of treating this chronic immune-mediated disease.

PAG gathering
Kick-off Women’s History Month & 2023 theme: celebrating women’s stories >

On March 8th, we celebrated International Women’s Day. The focus this year is on gender equity and celebrating women telling their stories. The B-NOW Belgian Chapter was thrilled to invite BMS Braine-l’Alleud-based employees to its first Lunch & Learn session of the year.

Reconnect
Innovative research pushes boundaries in the fight against cancer >

Cancer treatments are getting better, more diverse and more numerous. Although we still die from cancer, we are also increasingly recovering from it. Research, pharmaceutical companies, governments and private individuals are joining forces to fight cancer together.

For all media inquiries

Sabine de Beuf
Contact us for more information or to receive press material.

 

Sabine De Beuf

Head of Corporate Communications, Public Affairs & Patient Advocacy

 

Phone number: +32 2 352 76 11

E-mail: pressinfo.belgium@bms.com

 

 

If you are not a member of the press and have a non-media related question then find the right contact information here. This will enable us to help you faster!

Corporate Publications

In short

Who are we?

Learn more about the mission, vision and values of Bristol Myers Squibb Belgium

Facts and figures

The most important facts and figures at a glance

Our medicines

More information about the medicines distributed by Bristol Myers Squibb in Belgium

Our Research

Get an overview of our research for innovative medicines